New Published Data Show NeuroPace’s RNS® System Provides Patients with Unprecedented Seizure Reduction and Improved Quality of Life
Retrieved on:
Monday, July 27, 2020
The RNS System has been shown to dramatically reduce seizures and improve quality of life for people living with refractory epilepsy.
Key Points:
- The RNS System has been shown to dramatically reduce seizures and improve quality of life for people living with refractory epilepsy.
- Real-world data from a multicenter clinical study of the RNS System were published in Epilepsia, demonstrating seizure reductions not seen with any other neuromodulation system for refractory focal epilepsy.
- At three or more years, patients experienced an unprecedented 82% median reduction in seizure frequencythe highest reported for any neuromodulation system.
- Physicians reported that 75% of patients who received the RNS System were much improved or very much improved in their functioning at most recent follow up.